Shingo Eikawa

1.3k citations
21 papers · 987 · 1 hit paper · h-index 11

Impact in

  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immune cells in cancer
    • Immunotherapy and Immune Responses
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • T-cell and B-cell Immunology 8
    • Immunotherapy and Immune Responses 8
    • Immune Cell Function and Interaction 4
    • Cancer Immunotherapy and Biomarkers 5
    • CAR-T cell therapy research 2

Shingo Eikawa

20 papers receiving 979 citations

Shingo Eikawa's Hit Papers

Immune-mediated antitumor effect by type 2 diabetes drug, metformin 2015 · 433 citations
4330+3+7Years since publication100200300400

Peers

Shingo Eikawa
Comparison fields: 5 of 78
  • Immunology 433
  • Oncology 443
  • Cancer Research 174
  • Molecular Biology 501
  • Biological Psychiatry 12
Replace Chunjian Huang with:
Chunjian Huang United States
Yi-Ru Yu Switzerland
Jami Willette‐Brown United States
Fuqing Hu China
Jinren Zhou China
Chang Xian Li China
Amrita Nandan India
Hsin‐Yi Tseng Australia
Ian A. Bettencourt United States
Petros A. Tyrakis United Kingdom
Shingo Eikawa relative to Chunjian Huang United States Chunjian Huang's profile →
Citations per field
00.5×1.5×2.2×
Chunjian Huang · 1×
Citations per year

Countries citing papers authored by Shingo Eikawa

Since Specialization
Citations

This map shows the geographic impact of Shingo Eikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Eikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Eikawa more than expected).

Fields of papers citing papers by Shingo Eikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Eikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Eikawa. The network helps show where Shingo Eikawa may publish in the future.

Co-authors

The 25 scholars most cited alongside Shingo Eikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shingo Eikawa Line = papers co-authored together Shingo Eikawa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Immune-mediated antitumor effect by type 2 diabetes drug, metformin
Hit paper breakdown →
2015433
2 2017120
3 2018102
4 201965
5 201053
6 201448
7 202038
8 201133
9 201224
10 201221
11
Correlation of high and decreased NY-ESO-1 immunity to spontaneous regression and subsequent recurrence in a lung cancer patient.
200913
12 20147
13 20237
14 20155
15 20164
16 20163
17 20173
18 20133
19
[Metabolic Competition in Tumor Microenvironment].
20173
20
[Regulation of T-cell immune exhaustion and cancer immunotherapy].
20142

About Shingo Eikawa

Shingo Eikawa is a scholar working on Immunology, Oncology, Molecular Biology, Surgery and Cancer Research, having authored 21 papers that have together received 987 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (8 papers), Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Pancreatic function and diabetes (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (433 citations), Oncology (443 citations), Cancer Research (174 citations), Molecular Biology (501 citations) and Biological Psychiatry (12 citations). Shingo Eikawa has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Heiichiro Udono, Eiichi Nakayama, Mikako Nishida, Shusaku Mizukami, Chihiro Yamazaki, Yuki Kunisada, Takenori Uehara, Akiko Uenaka, Yoshihiro Ohue and Mikio Oka. Their work appears in journals such as Scientific Reports, International Journal of Cancer, Cancer Research, International Immunology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact